Anesta
Executive Summary
Former Abbott and Anaquest exec Thomas King joins as exec VP and chief operating officer of the Salt Lake City oral transmucosal drug delivery company. King was most recently VP-marketing and business at Somatogen. Anesta's first approved product, Fentanyl Oralet for anesthetic premedication and conscious sedation in monitored anesthesia care settings, is marketed by Abbott